From Plasminogen to Plasmin: Role of Plasminogen Receptors in Human Cancer

Author： Didiasova Miroslava Wujak Lukasz Wygrecka Malgorzata Zakrzewicz Dariusz

Publisher： MDPI

E-ISSN： 1422-0067|15|11|21229-21252

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.15, Iss.11, 2014-11, pp. : 21229-21252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Cell surface-associated proteolysis mediated by plasmin (PLA) is an essential feature of wound healing, angiogenesis and cell invasion, processes that are dysregulated in cancer development, progression and systemic spread. The generation of PLA, initiated by the binding of its precursor plasminogen (PLG) to the cell surface, is regulated by an array of activators, inhibitors and receptors. In this review, we will highlight the importance of the best-characterized components of the PLG/PLA cascade in the pathogenesis of cancer focusing on the role of the cell surface-PLG receptors (PLG-R). PLG-R overexpression has been associated with poor prognosis of cancer patients and resistance to chemotherapy. We will also discuss recent findings on the molecular mechanisms regulating cell surface expression and distribution of PLG-R.